SEC Form 4 · accession 0001127602-16-055225
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tommy G Thompson
Director
Period of report
Jun 8, 2016
Accepted (ET)
Jun 9, 2016 · 5:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2016 | M | 2,000 | $52.65 | A | 2,000 | D | |
| Common StockF1 | Jun 8, 2016 | S | 2,000 | $115.6237 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $52.65 | Jun 8, 2016 | M | 2,000 | D | Jan 1, 2011 | Jan 1, 2020 | Common Stock | 2,000 | 18,000 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $115.37 to $115.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.